Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
|
CN |
|
D
|
Dare Power Dekor Home Co Ltd
SZSE:000910
|
CN |
|
S
|
Shanghai Bolex Food Technology Co Ltd
SSE:603170
|
CN |
|
Sihui Fuji Electronics Technology Co Ltd
SZSE:300852
|
CN |
Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. The company is headquartered in Yichun, Jiangxi and currently employs 1,076 full-time employees. The company went IPO on 2017-03-31. The firm is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The firm's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The firm's products are sold to domestic and foreign markets, including Europe, North America and Japan.
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. The company is headquartered in Yichun, Jiangxi and currently employs 1,076 full-time employees. The company went IPO on 2017-03-31. The firm is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The firm's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The firm's products are sold to domestic and foreign markets, including Europe, North America and Japan.
